Search
Redefining Excellence in Liver Transplantation
UCSF Health’s highly skilled team of liver transplant specialists has extensive experience in treating medically complex, high-acuity patients while consistently achieving exceptional survival rates, according to the Scientific Registry of Transplant Recipients (SRTR).Degenerative Cervical Myelopathy: New Insights on a Common, Potentially Life-Altering Condition
Age-related spinal changes can be relatively benign – but they also can result in spinal cord dysfunction.Obesity Options in the Ozempic Era: An Expert’s Insights on BMI, GLP-1s and Surgery
Treating obesity is among the PCP's everyday duties, but when does a patient's body composition put them at risk and which treatments are appropriate?Beyond TAVR: Shaping the Next Era of Aortic Stenosis Management
Sammy Elmariah, MD, chief of Interventional Cardiology at UCSF, discusses the latest advances in treating aortic stenosis (AS).UCSF Stroke Clinic
The stroke clinic provides expert consultations and outpatient care to patients who are at risk of a stroke or have had a stroke due to neurovascular conditions.Acute Stroke Transfer Guide for Providers
Information resources for Acute Stroke Transfer Guide for Providers.Prenatal Enzyme Replacement Therapy for Lysosomal Storage Diseases
Pregnant patients with a diagnosed fetal lysosomal storage disease may have the opportunity to receive a promising treatment that could improve their babies’ health after birth.Aortic Valve Replacement: Ross Procedure
Learn more on the Aortic Valve Replacement: Ross Procedure.Neuromuscular Clinic Referral Guide
UCSF Neurologist to Receive Prestigious Scientific Award
Stephen L. Hauser, MD, Professor of Neurology and Director of the UCSF Weill Institute for Neurosciences, has been chosen by the American Brain Foundation (ABF) to receive its second annual Scientific Breakthrough Award. Hauser is being honored for his career-long commitment to advancing the understanding of the genetic basis, immune mechanisms and treatment of multiple sclerosis (MS).Why Do Some Long Covid Patients Continue to Have Difficulty Exercising?
While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.UCSF Urology Clinicians Present Research Findings at SurgeWest
This year’s program featured innovative research and discussions by experts from the UCSF Department of Urology.UCSF Study Finds a Better Way to Screen for Breast Cancer
A pioneering study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than automatically giving annual mammograms, can lower the chance of more advanced cancers, while still safely matching people to the amount of screening they need.UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term
The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025.The UCSF Breast Care Center
The UCSF Breast Care Center delivers integrated patient care from diagnosis through treatment and beyond at six locations across the Bay Area.Using AI in Electrocardiogram Analysis Can Improve Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UCSF study finds that Artificial Intelligence-enhanced (AI)-Electrocardiograms (ECG) may help identify the condition in its earliest stages and monitor important disease-related changes over time.UCSF Researchers Awarded Landmark Grant to Support Shoulder Osteoarthritis Research
The American Orthopaedic Society for Sports Medicine and the Arthritis Foundation have awarded a $500,000 multicenter research grant to UCSF Health’s Michael Davies, MD, and co-principal investigators Brian Feeley, MD, of UCSF and Robert Tashjian, MD of the University of Utah, for a first-of-its-kind collaboration intended to at advance research and treatment of osteoarthritis.UCSF Researcher Recognized for Excellence in Osteoarthritis Research and Regenerative Medicine
Kelsey H. Collins, PhD UCSF investigator Kelsey H. Collins, PhD, has been awarded the National Institutes of Health (NIH) Director’s “New Innovator Award” for her exceptional contributions to the fields of osteoarthritis research and regenerative medicine.UCSF Prostate Cancer Program Awarded SPORE Grant by National Cancer Institute
The UCSF Prostate Cancer Program of the Helen Diller Family Comprehensive Cancer Center is the recipient of the National Cancer Institute’s (NCI) Specialized Programs of Research Excellence (SPORE) grant for prostate cancer.Lauren Shapiro, MD, MS Secures Research Funding to Tackle Spanish-Speaking Patient Care Disparities
UCSF Department of Orthopaedic Surgery is pleased to announce that Lauren Shapiro, MD MS, an orthopaedic hand surgeon and medical researcher, has been awarded a prestigious K23 grant.One Million Dollar Gift Advances Patient Recovery Research with Groundbreaking Digital Tools
Jeannie Bailey, PhD, director of the Digital Orthopaedic Biomechanics Lab, and Bobby Tay, MD, chief of the UCSF Orthopaedic Spine Service, have been awarded a $1 million gift to support the development of digital tools designed to track and predict biomechanical recovery following surgery.AI in Cancer Care, Targeted Therapies Among Cancer Conference Talks
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat cancers and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference.Predictive Biomarkers, Tailored Therapy Among Conference Presentations
UCSF’s Eric J. Small, MD, becomes ASCO president at ASCO 2025 meetingThis New Treatment Can Adjust to Parkinson's Symptoms in Real Time
People with Parkinson’s disease have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.